Common gastrointestinal side effects include: Nausea and vomiting (affecting 1540% of patients, depending on the specific medication and dose) [13] [16] Diarrhoea (reported in 1030% of patients) Constipation (affecting 1020% of patients) Abdominal pain and discomfort Reduced appetite and early satiety Dyspepsia and gastro-oesophageal reflux symptoms These effects are generally dose-dependent and tend to improve over time as the body adjusts to the medication
In March 2024, the FDA approved Wegovy to reduce the risk of cardiovascular events, stroke, and heart attack in adults with cardiovascular disease and either obesity or overweight
Primary Care Physicians and Endocrinologists If you have a history of obesity or metabolic disorders , your primary care doctor or endocrinologist can prescribe semaglutide
Although basal XOR expression is typically low in humans, various factors such as hypoxia, ischemia-reperfusion injury, interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and corticosteroid treatment can markedly enhance XOR transcription
Sin embargo, como con todos los suplementos, puede haber algunos riesgos potenciales asociados con los suplementos de glutatin